← All stocks

Candel Therapeutics, Inc.

CADL Net buying
CIK 0001841387 #2585 in the set updated 17 Sep 2026
Bought (120 mo)
$12.51M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$7.69M
$1.28M on a plan · $3.50M straight out of an exercise
Sold at will
$2.90M
30 of 43 sales
Net
+$4.82M
+$9.61M against sales at will

By person

16 insiders · 67 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Manning Paul B
Director
$10.91M (5)
+$10.91M
4,052,437
$42.37M
Tak Paul Peter
Chief Executive Officer
$230.02K (3)
$4.21M (9) scheduled
−$3.98M
113,321
$1.18M
Martell Christopher
Director
$1.05M (3)
+$1.05M
671,863
$7.03M
+437.5%
Barone Francesca
Chief Scientific Officer
$1.99K (1)
$994.66K (7) scheduled
−$992.67K
77,362
$808.93K
+5,057%
Tyagarajan Seshu
Chief Technology Officer
$25.06K (2)
$921.76K (8)
−$896.70K
76,865
$803.73K
+284.3%
Nichols William Garrett
Chief Medical Officer
$763.79K (8) scheduled
−$763.79K
52,493
$548.89K
Aguilar-Cordova Estuardo
10% owner
$486.48K (6)
−$486.48K
3,455,764
$36.13M
−28.4%
Schoch Charles
Chief Financial Officer
$311.95K (5)
−$311.95K
43,391
$453.71K
−46.6%
Canepa John J
Chief Financial Officer
$81.00K (1)
+$81.00K
10,125
$105.87K
Nguyen Diem
Director
$80.00K (1)
+$80.00K
10,000
$104.56K
PAPA JOSEPH C
Director
$73.06K (2)
+$73.06K
102,271
$1.07M
Caffo Nathan
Chief Business Officer
$48.00K (1)
+$48.00K
6,000
$62.74K
Amello Jason
Chief Financial Officer
$10.00K (2)
+$10.00K
202,009
$2.11M
Aguilar Laura K.
10% owner
3,046,940
$31.86M
+5.5%
Nabel Gary J.
Director
5,353
$55.97K
Loggia Nicoletta
Director
2,141
$22.39K

No percentages here. This company's share count has moved by a factor of 2.4 over the window, from 32,475,537 to 76,518,565 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Tak Paul Peter
10 Sep 2026
Chief Executive Officer
Sold after exercise
220,866
$11.50
$2.54M
Nichols William Garrett
28 Jul 2025
Chief Medical Officer
Sold after exercise
937
$6.98
$6.54K
Nichols William Garrett
30 Jun 2025
Chief Medical Officer
Sold after exercise
781
$5.04
$3.94K
Barone Francesca
18 Mar 2025
Chief Scientific Officer
Sold after exercise
32,146
$8.76
$281.67K
Nichols William Garrett
18 Mar 2025
Chief Medical Officer
Sold after exercise
45,316
$8.76
$397.00K
Tyagarajan Seshu
17 Mar 2025
Chief Technology Officer
Sold after exercise
31,278
$8.82
$275.95K

What was left out

Form 4 filings counted 166
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 12
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 6
Sales at will 30
Transactions with no price 0
Shares from compensation/vesting 6,536,501
History held since 29 Jul 2021